These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 7468835

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The relationship of haloperidol concentrations to therapeutic response.
    Perry PJ, Pfohl BM, Kelly MW.
    J Clin Psychopharmacol; 1988 Feb; 8(1):38-43. PubMed ID: 3350997
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Haloperidol decanoate in schizophreniform disorders. Clinical and neuroendocrine aspects.
    Meco G, Casacchia M, Attenni M, Iafrate A, Castellana F, Ecari U.
    Acta Psychiatr Belg; 1983 Feb; 83(1):57-68. PubMed ID: 6613612
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic window of serum haloperidol concentration in acute schizophrenia and schizoaffective disorder.
    Ulrich S, Neuhof S, Braun V, Meyer FP.
    Pharmacopsychiatry; 1998 Sep; 31(5):163-9. PubMed ID: 9832347
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intensive treatment with haloperidol of treatment-resistant chronic schizophrenic patients.
    Hollister LE, Kim DY.
    Am J Psychiatry; 1982 Nov; 139(11):1466-8. PubMed ID: 7137396
    [Abstract] [Full Text] [Related]

  • 10. Haloperidol: therapeutic window in schizophrenia.
    Palao DJ, Arauxo A, Brunet M, Bernardo M, Haro JM, Ferrer J, Gonzalez-Monclus E.
    J Clin Psychopharmacol; 1994 Oct; 14(5):303-10. PubMed ID: 7806684
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Plasma clozapine and haloperidol concentrations in adolescents with childhood-onset schizophrenia: association with response.
    Piscitelli SC, Frazier JA, McKenna K, Albus KE, Grothe DR, Gordon CT, Rapoport JL.
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():94-7. PubMed ID: 7961584
    [Abstract] [Full Text] [Related]

  • 13. Cognitive changes in acute schizophrenia with brief neuroleptic treatment.
    Wahba M, Donlon PT, Meadow A.
    Am J Psychiatry; 1981 Oct; 138(10):1307-10. PubMed ID: 7294185
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Haloperidol and reduced haloperidol serum levels: correlation with psychopathology in acute schizophrenia.
    Stevens A, Mahal A, Gaertner HJ.
    Pharmacopsychiatry; 1992 Sep; 25(5):218-23. PubMed ID: 1409866
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Serum haloperidol concentration and clinical response in schizophrenia.
    Kirch DG, Bigelow LB, Korpi ER, Wagner RL, Zalcman S, Wyatt RJ.
    Schizophr Bull; 1988 Sep; 14(2):283-9. PubMed ID: 3201181
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.